NT-proBNP, the N-terminal pro-hormone of brain natriuretic peptide; NYHA, New York Heart Association.
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, Angiotensin receptor blockers; BB, β-blocker; LAD, left atrial dimension; LVEDD, left ventricular end-diastolic dimension; NTproBNP, the N-terminal pro-hormone of brain natriuretic peptide; NYHA, = New York Heart Association. ＃ Outcome were presented as counts (percentage) § HR, Hazard Ratios and P value were calculated with the use of stratified Cox proportional-hazard models adjusting with gender, age, and New York Heart Association functional class.
※ HR, Hazard Ratios and P value were calculated with the use of stratified Cox proportional-hazard models adjusting with gender, age, and New York Heart Association functional class and other drug treatments. Carriers of the risk G allele (Gly16) were benefited from βAR-blocker treatment in an allele-dose-dependent manner. The cumulative hazard curves for the AA homozygotes with and without β-blocker treatment (BB) are in black and in purple, respectively; those for AG heterozygotes are in green and in orange, and those for the GG homozygotes are in blue and in red. A transduction efficiency of more than 90% was obtained with Adeno-GFP at 100 multiplicity of infection (moi) in rat cardiac myocytes.
The transduction method had a low toxicity since more than 90% of the transduced cells maintained a healthy rod-shape morphology. 
